Literature DB >> 28233038

[Bladder storage and voiding dysfunctions : Side effects of drug therapy].

J Wolfesberger1, C E Falkensammer1, S Madersbacher2.   

Abstract

Bladder storage and voiding dysfunctions primarily affect patients aged 60 and upwards. Demographic changes and an age-related rise in prevalence underline the clinical relevance of these disorders. Besides behavior modification, the primary therapeutic approach is drug therapy. Therefore, a profound knowledge of the potential side effects is essential, particularly regarding the ever rising multidrug administration in the elderly. In this article, we provide a review concerning the potential adverse effects of the most popular therapeutic agents for bladder storage and voiding symptoms.

Entities:  

Keywords:  Alpha-blocker; Drug therapy; Micturition disorders; Muscarinic antagonists

Mesh：

Substances：

Year:  2017        PMID： 28233038     DOI： 10.1007/s00120-017-0339-y

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


  35 in total

Review 1.  American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults.

Authors: 
Journal:  J Am Geriatr Soc       Date:  2012-02-29       Impact factor: 5.562

2.  Evaluation of cognitive function in healthy older subjects treated with fesoterodine.

Authors:  Gary G Kay; Paul Maruff; David Scholfield; Bimal Malhotra; Laurence Whelan; Amanda Darekar; Diane L Martire
Journal:  Postgrad Med       Date:  2012-05       Impact factor: 3.840

3.  Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats.

Authors:  Annamaria Morelli; Erica Sarchielli; Paolo Comeglio; Sandra Filippi; Rosa Mancina; Mauro Gacci; Linda Vignozzi; Marco Carini; Gabriella B Vannelli; Mario Maggi
Journal:  J Sex Med       Date:  2011-08-03       Impact factor: 3.802

Review 4.  Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.

Authors:  Abdulmaged M Traish; John Hassani; Andre T Guay; Michael Zitzmann; Michael L Hansen
Journal:  J Sex Med       Date:  2010-12-22       Impact factor: 3.802

5.  The pharmacovigilance of tamsulosin: event data on 12484 patients.

Authors:  R D Mann; P Biswas; S Freemantle; G Pearce; L Wilton
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

6.  Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.

Authors:  Kaycee M Sink; Joseph Thomas; Huiping Xu; Bruce Craig; Steven Kritchevsky; Laura P Sands
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

7.  A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β₃ adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder.

Authors:  Sender Herschorn; Jack Barkin; David Castro-Diaz; Jeffrey M Frankel; Montserrat Espuna-Pons; Angelo E Gousse; Matthias Stölzel; Nancy Martin; Adrie Gunther; Philip Van Kerrebroeck
Journal:  Urology       Date:  2013-06-13       Impact factor: 2.649

Review 8.  A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder.

Authors:  Giacomo Novara; Antonio Galfano; Silvia Secco; Carolina D'Elia; Stefano Cavalleri; Vincenzo Ficarra; Walter Artibani
Journal:  Eur Urol       Date:  2008-07-09       Impact factor: 20.096

9.  Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial.

Authors:  Vik Khullar; Gerard Amarenco; Javier C Angulo; Javier Cambronero; Kjetil Høye; Ian Milsom; Piotr Radziszewski; Tomasz Rechberger; Peter Boerrigter; Ted Drogendijk; Marianne Wooning; Christopher Chapple
Journal:  Eur Urol       Date:  2012-11-06       Impact factor: 20.096

Review 10.  Complications of cataract surgery in patients with BPH treated with alpha 1A-blockers.

Authors:  Slawomir Jan Teper; Dariusz Dobrowolski; Edward Wylegala
Journal:  Cent European J Urol       Date:  2011-06-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.